rs185011953
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001277115.2(DNAH11):c.470G>A(p.Gly157Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000135 in 1,610,530 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH11 | ENST00000409508.8 | c.470G>A | p.Gly157Glu | missense_variant | 2/82 | 5 | NM_001277115.2 | ENSP00000475939.1 | ||
DNAH11 | ENST00000607050.1 | n.460G>A | non_coding_transcript_exon_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000784 AC: 119AN: 151882Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000197 AC: 48AN: 244060Hom.: 0 AF XY: 0.000197 AC XY: 26AN XY: 132232
GnomAD4 exome AF: 0.0000679 AC: 99AN: 1458530Hom.: 1 Cov.: 31 AF XY: 0.0000607 AC XY: 44AN XY: 725184
GnomAD4 genome AF: 0.000783 AC: 119AN: 152000Hom.: 0 Cov.: 31 AF XY: 0.000767 AC XY: 57AN XY: 74308
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 27, 2013 | Variant classified as Uncertain Significance - Favor Benign. The Gly157Glu varia nt in DNAH11 has not been previously identified in individuals with pulmonary di sease. This variant has been identified in 0.19% (7/3676) African American chrom osomes by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs185011953). The Glycine residue at this position is not well conserved across evolutionarily distant species, and the variant residue (Glutamic acid) h as been observed in two mammalian species (shrew and platypus). Additional compu tational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, the lack of evolutionary conservation suggests that this variant may be more likely benign, but additional information is needed to fully assess its cl inical significance. - |
Primary ciliary dyskinesia 7 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jan 31, 2022 | The DNAH11 c.470G>A; p.Gly157Glu variant (rs185011953), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 163093). This variant is found in the African population with an allele frequency of 0.2% (59/23,860 alleles) in the Genome Aggregation Database. The glycine at codon 157 is moderately conserved, and computational analyses predict that this variant is neutral (REVEL: 0.037). Given the lack of clinical and functional data, the significance of the p.Gly157Glu variant is uncertain at this time. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at